Evidence map›Paper›PMID 40305476›Full record

SynthesisPLoS neglected tropical diseases2025

Vector competence for Oropouche virus: A systematic review of pre-2024 experiments.

Emily N Gallichotte, Gregory D Ebel, Colin J Carlson

Abstract readSystematic Review
In one paragraph

Synthesis in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. The global outbreak of Oropouche virus: surveillance of global trends.Tropical diseases, travel medicine and vaccines · 2026
    Review
  12. Viruses · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emily N GallichotteDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.ORCID 0000-0002-8937-5583
Gregory D EbelDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.
Colin J CarlsonDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.

Funding

National Science Foundation DBI 2021909National Science Foundation DBI 2213854National Science Foundation DBI 2515340
6 · The paper itself

Abstract

The 2023-24 epidemic of Oropouche fever in the Americas and the associated ongoing outbreak in Cuba suggests a potential state shift in the epidemiology of the disease, raising questions about which vectors are driving transmission. In this study, we conduct a systematic review of vector competence experiments with Oropouche virus (OROV, Orthobunyavirus) that were published prior to the 2023-24 epidemic season. Only seven studies were published by September 2024, highlighting the chronic neglect that Oropouche virus (like many other orthobunyaviruses) has been subjected to since its discovery in 1954. Two species of midge (Culicoides paraensis and C. sonorensis) consistently demonstrate a high competence to transmit OROV (~30%), while mosquitoes (including both Aedes and Culex spp.) exhibited an infection rate consistently below ~20%, and showed limited OROV transmission. Further research is needed to establish which vectors are involved in the ongoing outbreak in Cuba, and whether local vectors and wildlife communities create any risk of establishment in non-endemic regions.

Indexed as

Bunyaviridae InfectionsCeratopogonidaeInsect VectorsMosquito VectorsOrthobunyavirusAedesAnimalsCubaCulexHumans

Identifiers

PMID40305476
PMCPMC12043118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.